Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section listing study sites by state and updated the revision to v3.3.3.SummaryDifference3%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.3.2 from v3.2.0. This appears to be a page version update rather than a modification to study details or content.SummaryDifference0.0%

- Check41 days agoChange DetectedThe government funding/operating status notice was removed from the page; no other content changes were made.SummaryDifference0.3%

- Check55 days agoChange Detected- No modifications detected to core study information (title, conditions, intervention, eligibility, and locations). The page content remains as previously presented.SummaryDifference0.2%

- Check84 days agoChange DetectedUpdated to v3.2.0 with a government-status notice; removed v3.1.0.SummaryDifference5%

- Check91 days agoChange DetectedThe page has updated its version to v3.1.0 and added a contact phone number (844-845-4682); it no longer references v3.0.2.SummaryDifference0.1%

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.